Interestingly, both the knockdown of LIX1L using shRNA and the reduction of phosphorylated LIX1L using PY136 peptide inhibited cancer cell proliferation in vitro and in vivo and decreased phosphorylated Cofilin. The gene discussed is CFL1; the disease is cancer.